Ted W. Love

Insider Reports History

Entity
Individual
Location
C/O Global Blood Therapeutics, Inc., 400 East Jamie Court, Suite 101, South San Francisco, CA
Signature
/s/ Jun Yoon, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ted W. Love:

Insider Reports Filed by Ted W. Love

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GPCR Structure Therapeutics Inc. Jun 25, 2024 1 $0 4 Jun 27, 2024 Director
RPRX Royalty Pharma plc Jun 7, 2024 1 $0 4 Jun 10, 2024 Director
GILD GILEAD SCIENCES, INC. May 8, 2024 2 $0 4 May 9, 2024 Director
GILD GILEAD SCIENCES, INC. Feb 2, 2024 2 $0 4 Feb 6, 2024 Director
GILD GILEAD SCIENCES, INC. Feb 1, 2024 0 $0 3 Feb 6, 2024 Director
SGEN Seagen Inc. Dec 14, 2023 6 -$974K 4 Dec 15, 2023 Director
GPCR Structure Therapeutics Inc. Aug 3, 2023 1 $0 4 Aug 4, 2023 Director
GPCR Structure Therapeutics Inc. Aug 3, 2023 0 $0 3 Aug 4, 2023 Director
RPRX Royalty Pharma plc Jun 23, 2023 1 $0 4 Jun 26, 2023 Director
SGEN Seagen Inc. May 31, 2023 1 $0 4 Jun 2, 2023 Director
GBT Global Blood Therapeutics, Inc. Oct 5, 2022 18 $0 4 Oct 6, 2022 President and CEO, Director
GBT Global Blood Therapeutics, Inc. Sep 27, 2022 6 $300K 4 Sep 29, 2022 President and CEO, Director
GBT Global Blood Therapeutics, Inc. Sep 1, 2022 5 -$627K 4 Sep 6, 2022 President and CEO, Director
GBT Global Blood Therapeutics, Inc. Aug 1, 2022 4 -$325K 4 Aug 3, 2022 President and CEO, Director
RPRX Royalty Pharma plc Jun 24, 2022 1 $0 4 Jun 24, 2022 Director
SGEN Seagen Inc. May 13, 2022 2 $0 4 May 17, 2022 Director
GBT Global Blood Therapeutics, Inc. Mar 1, 2022 7 -$100K 4 Mar 3, 2022 President and CEO, Director
GBT Global Blood Therapeutics, Inc. Feb 1, 2022 5 -$309K 4 Feb 3, 2022 President and CEO, Director
GBT Global Blood Therapeutics, Inc. Sep 1, 2021 3 -$140K 4 Sep 3, 2021 President and CEO, Director
GBT Global Blood Therapeutics, Inc. Aug 1, 2021 5 -$406K 4/A Sep 24, 2021 President and CEO, Director
RPRX Royalty Pharma plc Jun 25, 2021 1 $0 4 Jun 29, 2021 Director
SGEN Seagen Inc. May 14, 2021 2 $0 4 May 18, 2021 Director
GBT Global Blood Therapeutics, Inc. Jul 1, 2016 1 -$84.4K 4/A Jan 6, 2022 President and CEO, Director